Paid Clinical Trials Oklahoma

Discover 832 paid clinical trials in Oklahoma. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 832

EVO756A Study Evaluating the Safety, Tolerability, and Efficacy of EVO756 in Adults with Chronic Inducible Urticaria

Recruiting

PHASE2

Sponsor:

Evommune, Inc.

Location:

Oklahoma City OK, Pflugerville TX, Baton Rouge LA, Birmingham ALshow 14 more

Code:

NCT06603220

Conditions

Chronic Inducible Urticaria

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

Oral EVO756

Radiation Therapy with AtezolizumabStudy of Radiation Therapy Followed by Atezolizumab in Stage II or III Non-small Cell Lung Cancer Patients

Recruiting

PHASE2

Sponsor:

National Cancer Institute (NCI)

Location:

Oklahoma City OK, Lawton OK, Richardson TX, Dallas TXshow 101 more

Code:

NCT04310020

Conditions

Lung Non-Small Cell Carcinoma

Stage II Lung Cancer AJCC v8

Stage III Lung Cancer AJCC v8

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Atezolizumab

Biospecimen Collection

Computed Tomography

Hypofractionated Radiation Therapy

Magnetic Resonance Imaging

N-acetylcysteineOral N-acetylcysteine for Retinitis Pigmentosa

Recruiting

PHASE3

Sponsor:

Johns Hopkins University

Location:

Oklahoma City OK, Dallas TX, Iowa City IA, Nashville TNshow 21 more

Code:

NCT05537220

Conditions

Retinitis Pigmentosa

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

N-acetylcysteine

Placebo

Observational StudyA Longitudinal Observational Study of Patients Undergoing Therapy for IMISC

Recruiting

Sponsor:

Target PharmaSolutions, Inc.

Location:

Oklahoma City OK, Fort Smith AR, Frisco TX, Lewisville TXshow 51 more

Code:

NCT03661866

Conditions

Atopic Dermatitis

Alopecia Areata

Hidradenitis Suppurativa

Vitiligo

Psoriasis

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Radiation TherapyRegistry Study for Radiation Therapy Outcomes

Recruiting

Sponsor:

Proton Collaborative Group

Location:

Oklahoma City OK, Overland Park KS, Kansas City KS, Shreveport LAshow 19 more

Code:

NCT01255748

Conditions

Neoplasms

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

Proton Therapy, Photon Therapy, SRS, Brachytherapy

AGN-193408AGN-193408 SR in the Treatment of Open-angle Glaucoma or Ocular Hypertension

Recruiting

PHASE1

PHASE2

Sponsor:

AbbVie

Location:

Oklahoma City OK, Kansas City MO, Austin TX, Memphis TNshow 33 more

Code:

NCT04499248

Conditions

Open-angle Glaucoma

Ocular Hypertension

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

AGN-193408 SR

Lumigan

Sham Administration

Lumigan Vehicle

Total Ablative TherapyTesting the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, the ERASur Study

Recruiting

PHASE3

Sponsor:

Alliance for Clinical Trials in Oncology

Location:

Oklahoma City OK, Springfield MO, Southhaven MS, Memphis TNshow 97 more

Code:

NCT05673148

Conditions

Metastatic Colorectal Adenocarcinoma

Stage IV Colorectal Cancer AJCC V8

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Stereotactic Ablative Radiotherapy

Resection

Microwave Ablation

Chemotherapy

Computed Tomography

Amlitelimab with Topical CorticosteroidsA Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis on Background Topical Corticosteroids

Recruiting

PHASE3

Sponsor:

Sanofi

Location:

Tulsa OK, Fort Smith AR, Mesquite TX, Lee's Summit MOshow 45 more

Code:

NCT06224348

Conditions

Dermatitis Atopic

Eligibility Criteria

Sex: All

Age: 12+

Healthy Volunteers: Not accepted

Interventions

Amlitelimab

Placebo

Topical corticosteroids

Topical calcineurin inhibitors

Luveltamab Tazevibulin vs. IC ChemotherapyREFRaME-O1: A Study to Investigate the Efficacy and Safety of Luveltamab Tazevibulin Versus Investigator's Choice (IC) Chemotherapy in Women With Ovarian Cancer (Including Fallopian Tube or Primary Peritoneal Cancers) Expressing FOLR1

Recruiting

PHASE2

PHASE3

Sponsor:

Sutro Biopharma, Inc.

Location:

Tulsa OK, Dallas TX, The Woodlands TX, Omaha NEshow 22 more

Code:

NCT05870748

Conditions

Ovarian Cancer

Epithelial Ovarian Cancer

Fallopian Tube Cancer

Primary Peritoneal Cancer

Platinum-resistant Ovarian Cancer

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Luveltamab tazevibulin

Pegfilgrastim

Gemcitabine

Paclitaxel

Pegylated liposomal doxorubicin

Heart FailureFast Induced Remodeling in Heart Failure with Preserved Ejection Fraction

Recruiting

Sponsor:

Medtronic Cardiac Rhythm and Heart Failure

Location:

Oklahoma City OK, Dallas TX, Kansas City KS, Houston TXshow 4 more

Code:

NCT05839730

Conditions

Heart Failure with Preserved Ejection Fraction

Concentric Hypertrophy

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Pacemaker PLR + TRT ON

Pacemaker non-pacing mode or an exertional rate-adaptive pacing mode with no planned pacing at rest.

Popular cities in Oklahoma

Norman Tulsa Oklahoma City